Abstract
The aim of this study was to retrospectively assess the prognostic value of p53 and bcl-2 protein expression, cell proliferation index (Mib-1 index), and tumor microvessel density (factor VIII-related antigen) in pediatric medulloblastoma patients. Tumor specimens of 55 patients (age 2–18 years) with medulloblastoma treated with a curative intent between 1972 and 1991 were studied. Slides of paraffin embedded tissue were stained with monoclonal antibodies (mAb) and examined under high power light microscopy for the presence of immunoreactivity. Microvessel density was scored both in the area of most intense staining (‘Angio-max’) and in 3 additional randomly selected areas. The sum of these 4 scores was termed ‘Angio-total’. ‘Angio-max’ and ‘Angio-total’ were evaluated separately by two independent investigators to assess reproducibility. None of the parameters studied, i.e. p53 or bcl-2 expression, Mib-1 index or microvessel density scores were associated with patient survival. Microvessel scores between observers were significantly but weakly correlated, with correlation coefficients (r)<0.5 for both ‘Angio-max’ and ‘Angio-total’. Leptomeningeal spread at diagnosis was the only independent factor associated with a poor survival (p=0.003). There was no association of leptomeningeal metastasis with any of the biological markers tested in this study.
Similar content being viewed by others
References
Yasue M, Tomita T, Engelhard H, Gonzalez-Crussi F, McLone DG, Bauer KD: Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70: 385–391, 1989
Tait DM, Eeles RA, Carter R, Ashley S, Ormerod MG: Ploidy and proliferative index in medulloblastoma: useful prognostic factors? Eur J Cancer 29A: 1383–1387, 1993
Gajjar AJ, Heideman RL, Douglass EC, Kun LE, Kovnar EH, Sanford RA, Fairclough DL, Ayers D, Look AT: Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 11: 2211–2217, 1993
Ito S, Hoshino T, Prados MD, Edwards MSB: Cell kinetics of medulloblastomas. Cancer 70: 671–678, 1992
Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study withMIB1 monoclonal antibody on archival material. Acta Neuropathol 87: 47–54, 1994
Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 87: 362–370, 1994
Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347–2350, 1990
MacGregor DN, Ziff EB: Elevated c-myc expression in childhood medulloblastomas. Pediatr Res 28: 63–68, 1990
McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Cogen PH: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229–232
Batra SK, McLendon RE, Koo JS, Castellino-Prabhu S, Fuchs HE, Krisher JP, Friedman HS, Bigner DD, Bigner SH: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neuro-Oncol 24: 39–45, 1995
Weidner N, Semple JP, Welch WR, Folkman J:Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1–8, 1991
Germano IM, Ito M Cho KG, Hoshino T, Davis RL, Wilson CB: Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 70: 701–706, 1989
Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82–86, 1994
Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362–372, 1996
Chang CH, Housepian EM, Herbert Jr CJ: An operative staging and amegavoltage radiotherapy technique for cerebellar medulloblastoma. Radiology 93: 1351–1359, 1969
Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC: bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94: 369–375, 1997
Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saitu: Expression of p53, MDM2 protein, and Ki-67 antigen in recurrent meningiomas. J Neuro-Oncol 38: 41–49, 1998
Jaros E, Lunec J, Perry RH, Kelly PJ, Pearson ADJ: p53 protein overexpression identifies a group of central primitive neuroectodermal tumors with poor prognosis. Br J Cancer 68: 801–807, 1993
Saylors RL III, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721–4723, 1991
Hui-Kuo SG, Burman F, Dee S, Israel MA: Differential induction of p53-mediated apoptosis in medulloblastomas and gliomas correlates with their ability to induce bax. Int J Radiat Oncol Biol Phys 39(suppl): 178, 1997
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336, 1990
Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879–886, 1992
Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JCI: Immunohistochemical analysis of bcl-2, bcl-x, mcl-1, and bax in tumors of central and peripheral nervous system origin.AmJ Pathol 150: 805–814, 1997
Heck K, Pyle P, Bruner JH: bcl-2 expression in cerebellar medulloblastomas. Brain Pathol 4: 438, 1994
Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa H: bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 88: 520–526, 1994
Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neuro-Oncol 27: 101–109, 1996
Ballantyne ES, McDowell H, May PL, Gosden C: Childhood medulloblastoma: bcl-2 expression and survival. J Neuro-Oncol 30: 99, 1996
Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T: Expression of bcl-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 45: 230–235, 1996
Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55: 999–1001, 1995
Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21: 352–361, 1995
Jay V, Parkinson D, Becker L, Chan FW: Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki-67 quantification and flowcytometry. Pediatr Pathol 14: 253–276, 1994
Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119–122, 1998
Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neuro-Oncol 32: 253–265, 1997
Pietsch T, Valter MM, Wolf HK, Von Deimling A, Su Huang HJ, Cavenee WK, Wiestler OD: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93: 109–117, 1997
Taomoto K, Tomita T, Raimondi AJ, Leestma JE: Medulloblastomas in childhood: histological factors influencing patient's outcome. Child Nerv Syst 3: 354–360, 1987
Vermeulen PB, Gasparini SB, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474–2484
Barbareschi M, Weidner N, Gasparini G: Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided analysis system. Appl Immunohistochem 3: 75–84, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miralbell, R., Tolnay, M., Bieri, S. et al. Pediatric Medulloblastoma: Prognostic Value of p53, bcl-2, Mib-1, and Microvessel Density. J Neurooncol 45, 103–110 (1999). https://doi.org/10.1023/A:1006330324991
Issue Date:
DOI: https://doi.org/10.1023/A:1006330324991